Arbutus Biopharma GAAP EPS of -$0.03 misses by $0.01, revenue of $1.01M beats by $0.33M (ABUS:NASDAQ)
· seekingalpha.com
Arbutus Biopharma (ABUS) Q2 earnings: GAAP EPS -$0.03 misses by $0.01; revenue $1.01M down 90.6% Y/Y but beats estimates.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...